EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polysarcosine-based lipid formulations for intracranial delivery of mRNA

Dongdong Bi, Dennis Mark Unthan, Lili Hu, Jeroen Bussmann, Katrien Remaut, Matthias Barz, Heyang Zhang

Journal of Controlled Release · 2023-04 · 356 · 1-13

DOI: 10.1016/j.jconrel.2023.02.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-04. Verfasst von Dongdong Bi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333, CC, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Liposomes, Sarcosine. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) is revolutionizing the future of therapeutics in a variety of diseases, including neurological disorders. Lipid formulations have shown to be an effective platform technology for mRNA delivery and are the basis for the approved mRNA vaccines. In many of these lipid formulations, polyethylene glycol (PEG)-functionalized lipid provides steric stabilization and thus plays a key role in improving the stability both ex vivo and in vivo. However, immune responses towards PEGylated lipids may compromise the use of those lipids in some applications (e.g., induction of antigen specific tolerance), or within sensitive tissues (e.g., central nervous system (CNS)). With respect to this issue, polysarcosine (pSar)-based lipopolymers were investigated as an alternative to PEG-lipid in mRNA lipoplexes for controlled intracerebral protein expression in this study. Four polysarcosine-lipids with defined sarcosine average molecular weight (Mn = 2 k, 5 k) and anchor diacyl chain length (m = 14, 18) were synthesized, and incorporated into cationic liposomes. We found that the content, pSar chain length and carbon tail lengths of pSar-lipids govern the transfection efficiency and biodistribution. Increasing carbon diacyl chain length of pSar-lipid led up to 4- and 6-fold lower protein expression in vitro. When the length of either pSar chain or lipid carbon tail increased, the transfection efficiency decreased while the circulation time was prolonged. mRNA lipoplexes containing 2.5% C14-pSar2k resulted in the highest mRNA translation in the brain of zebrafish embryos through intraventricular injection, while C18-pSar2k-liposomes showed a comparable circulation with DSPE-PEG2k-liposomes after systemic administration. To conclude, pSar-lipid enable efficient mRNA delivery, and can substitute PEG-lipids in lipid formulations for controlled protein expression within the CNS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesSarcosineAnimalsRNA, MessengerZebrafishTissue DistributionPolyethylene GlycolsTransfectionLipidsPeptides

Stichwörter der Autor:innen

Lipid formulationsPolysarcosineZebrafish embryomRNA intracerebral delivery

Substanzen

LiposomesSarcosineRNA, MessengerPolyethylene GlycolsLipidspolysarcosinePeptides

Autor:innen und Institutionen

  • Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333, CC, Leiden, the Netherlands.
  • Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.
  • Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333, CC, Leiden, the Netherlands; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, La…
  • Leiden Academic Centre for Drug Research (LACDR), Leiden University, Einsteinweg 55, 2333, CC, Leiden, the Netherlands. Electronic address: h.zhang@lacdr.leidenuniv.nl.

Förderung

  • Deutsche Forschungsgemeinschaft
  • China Scholarship Council

Zitieren

APA

Bi, D., Unthan, D. M., Hu, L., Bussmann, J., Remaut, K., Barz, M., & Zhang, H. (2023). Polysarcosine-based lipid formulations for intracranial delivery of mRNA. Journal of Controlled Release, 356, 1-13. https://doi.org/10.1016/j.jconrel.2023.02.021

Vancouver

Bi D, Unthan DM, Hu L, Bussmann J, Remaut K, Barz M, et al. Polysarcosine-based lipid formulations for intracranial delivery of mRNA. Journal of Controlled Release. 2023;356:1-13. doi:10.1016/j.jconrel.2023.02.021

BibTeX
@article{Bi2023,
  author = {Bi, Dongdong and Unthan, Dennis Mark and Hu, Lili and Bussmann, Jeroen and Remaut, Katrien and Barz, Matthias and Zhang, Heyang},
  title = {Polysarcosine-based lipid formulations for intracranial delivery of mRNA},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {356},
  pages = {1--13},
  doi = {10.1016/j.jconrel.2023.02.021}
}
Kostenlos starten →